AK111
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for AK111, covering 2024-03-06 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis [Phase 3]